GENE ONLINE|News &
Opinion
Blog

Roche
Roche’s Elecsys GALAD Score that Predicts HCC Occurrence, Bags Breakthrough Designation
2020-03-06
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
Polivy – A New and Improved Arsenal from Roche to Fight DLBCL Relapse
2020-01-24
GeneOnline’s Top Mergers and Acquisitions of 2019
2019-12-31
Comprehensive Genomic Profiling at the Cusp of Modern Precision Oncology: Interview with Dr. Nicolas Martin 
2019-12-03
Rozlytrek Becomes the Third Tumor-Agnostic Medicine to be Approved by the USFDA
2019-08-21
Weekly in Asia 20190616-0622
2019-06-27
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Cambridge startup, GO Therapeutics make $195 million deal with Roche
2018-10-05
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
1 5 6 7
LATEST
One in Four U.S. Adults Turns to AI Tools for Health Care Advice
2026-04-15
Policy, Pricing, and Power: Why Europe’s Biotech Future Depends on Openness, Not Overregulation
2026-04-14
Vitiligo: Causes, Life-Changing Impacts, Treatment Challenges, and Breakthrough New Drugs
2026-04-14
Chris Chen Presents Faraday Future AI Robotics Advancements at Harvard Science Center
2026-04-14
General Lance W. Lord to Receive Space Foundation Lifetime Space Achievement Award for Leadership in Military Space Operations
2026-04-14
Ronald Kopas Reports 11.2 Percent Ownership in Delta Resources Following Private Share Acquisition
2026-04-14
Alcoa Corporation to Redeem $219 Million of 6.125% Notes Due 2028
2026-04-14
Scroll to Top